Cargando…
P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430650/ http://dx.doi.org/10.1097/01.HS9.0000970108.74214.75 |
_version_ | 1785091017244934144 |
---|---|
author | Piasecki, Julia Desai, Keyur Courtney, Carolyn Thompson, Ethan Pratt, James Raje, Noopur Patel, Krina Raab, Marc S. Cook, Mark Simonsen, Katy Popa Mckiver, Mihaela Kaiser, Shari Martin, Nathan |
author_facet | Piasecki, Julia Desai, Keyur Courtney, Carolyn Thompson, Ethan Pratt, James Raje, Noopur Patel, Krina Raab, Marc S. Cook, Mark Simonsen, Katy Popa Mckiver, Mihaela Kaiser, Shari Martin, Nathan |
author_sort | Piasecki, Julia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104306502023-08-17 P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA Piasecki, Julia Desai, Keyur Courtney, Carolyn Thompson, Ethan Pratt, James Raje, Noopur Patel, Krina Raab, Marc S. Cook, Mark Simonsen, Katy Popa Mckiver, Mihaela Kaiser, Shari Martin, Nathan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430650/ http://dx.doi.org/10.1097/01.HS9.0000970108.74214.75 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Piasecki, Julia Desai, Keyur Courtney, Carolyn Thompson, Ethan Pratt, James Raje, Noopur Patel, Krina Raab, Marc S. Cook, Mark Simonsen, Katy Popa Mckiver, Mihaela Kaiser, Shari Martin, Nathan P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA |
title | P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA |
title_full | P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA |
title_fullStr | P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA |
title_full_unstemmed | P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA |
title_short | P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA |
title_sort | p801: baseline and early post-infusion biomarkers associated with optimal response to idecabtagene vicleucel (ide-cel) in the karmma-3 study of triple-class–exposed relapsed and refractory multiple myeloma |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430650/ http://dx.doi.org/10.1097/01.HS9.0000970108.74214.75 |
work_keys_str_mv | AT piaseckijulia p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT desaikeyur p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT courtneycarolyn p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT thompsonethan p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT prattjames p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT rajenoopur p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT patelkrina p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT raabmarcs p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT cookmark p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT simonsenkaty p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT popamckivermihaela p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT kaisershari p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma AT martinnathan p801baselineandearlypostinfusionbiomarkersassociatedwithoptimalresponsetoidecabtagenevicleucelidecelinthekarmma3studyoftripleclassexposedrelapsedandrefractorymultiplemyeloma |